Shopping Cart
Remove All
Your shopping cart is currently empty
AG-024322 is a potent ATP-competitive inhibitor targeting pan-CDK, effectively inhibiting cell cycle kinases CDK1, CDK2, and CDK4 with Ki values in the 1-3 nM range (1-3 nM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $699 | - | In Stock |
| Description | AG-024322 is a potent ATP-competitive inhibitor targeting pan-CDK, effectively inhibiting cell cycle kinases CDK1, CDK2, and CDK4 with Ki values in the 1-3 nM range (1-3 nM). |
| Targets&IC50 | HCT116 cells:120 nM, CDK2:3 nM (ki), CDK4:2.9 nM (Ki), CDK1:2.3 nM (Ki), CDK1:2.3 nM (ki), CDK2:3 nM (Ki), CDK4:2.9 nM (ki) |
| In vitro | Biotin-PEG4-Picolyl azide can utilize the ubiquitin-proteasome system to achieve selective elimination of target proteins through E3 ubiquitin ligase-mediated specific degradation of target proteins [1]. |
| In vivo | In male and female cynomolgus monkeys, AG-024322 (at doses of 2, 6, and 10 mg/kg; intravenous infusion; over 5 days) resulted in dose-dependent pancytopenic bone marrow hypocellularity and lymphoid depletion in lymph nodes, spleen, and/or thymus at doses greater than 6 mg/kg[1]. |
| Synonyms | AG-024322, AG024322, AG 024322 |
| Molecular Weight | 418.44 |
| Formula | C23H20F2N6 |
| Cas No. | 837364-57-5 |
| Smiles | CCNCc1cncc(-c2ccc3[nH]nc(-c4nc5cc(F)cc(F)c5[nH]4)c3c2)c1C |
| Relative Density. | 1.361 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (191.19 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (7.89 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.